NCT04505813 2024-01-16Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple MyelomaNexImmune Inc.Phase 1/2 Suspended9 enrolled
NCT03752541 2022-05-20Efficacy and Safety Evaluation of BCMA-UCARTBioray LaboratoriesPhase NA Suspended20 enrolled